Well, that's not actually how it works under the law. The
Well, that's not actually how it works under the law. The law doesn't sit back and wait possibly YEARS to see if a drug works or not if someone in a position of responsibility like a CEO makes millions while others drown based on statements that, by law, a CEO should not make.
It'd be akin to saying "Well, the doctor left a sponge in the patient and they got an infection, but hey, they survived just fine, so no malpractice."
The DOJ knows what they're doing and wouldn't bring an indictment where they need to "step easy on the allegations." When you're indicted like this, it's pretty heavy.
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Upcoming Half Year Results Presentation by IBA Louvain-la-Neuve, Belgium - IBA (Ion Beam Applications S.A.) is gearing up to present its consolidated results for the half year 2025. The company, renowned for its leadership in particle accelerator technology, will unveil this significant information on a designated date set for Thursday, 28 August 2025. The results will be...
Continue Reading
Akila Partners with Jotun for AI Energy Management Jotun, a leading global paints and coatings manufacturer, has chosen Akila to implement an advanced AI-driven energy platform across its extensive manufacturing portfolio. This initiative will be deployed in numerous production sites worldwide, reaching across various regions. Significance of the Partnership This...
Continue Reading
Granite Construction Incorporated's Q3 2024 Results Breakdown Granite Construction Incorporated (NYSE: GVA) has proudly announced remarkable results from the third quarter of 2024, culminating in a successful financial performance. The company showed positive trends in revenue and profit margins, indicating a robust recovery and growth in the construction sector. Key...
Continue Reading
Overview of the Automotive Hypervisor Market The Automotive Hypervisor Market is on track for significant growth, with projections estimating it will reach $566 million by 2027, reflecting a compound annual growth rate (CAGR) of 27.0% from its 2022 value of $171 million. This rapid expansion is largely attributed to the increasing necessity for consolidating electronic...
Continue Reading
Cash Dividend Announcement Hawthorn Bancshares, Inc. has made an important announcement regarding its financial commitment to its shareholders. The company's Board of Directors has decided to approve a quarterly cash dividend of $0.20 per common share. This dividend is set to be payable on October 1, 2025, to those shareholders who are on record as of the close of...
Continue Reading
